These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 19681114)
21. Myocardial protection with a beta blocker and glycoprotein IIb/IIIa inhibitor during PCI: attractive concept, but limited evidence of benefit. Leesar MA Catheter Cardiovasc Interv; 2008 Oct; 72(4):498-9. PubMed ID: 18819148 [No Abstract] [Full Text] [Related]
22. Tug of war. Manoukian SV Am J Cardiol; 2009 Sep; 104(5 Suppl):1C-3C. PubMed ID: 19695353 [No Abstract] [Full Text] [Related]
23. Antiplatelet therapies and the role of antiplatelet resistance in acute coronary syndrome. Dupont AG; Gabriel DA; Cohen MG Thromb Res; 2009 May; 124(1):6-13. PubMed ID: 19324398 [TBL] [Abstract][Full Text] [Related]
24. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients. Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028 [TBL] [Abstract][Full Text] [Related]
25. Clinical implications and management of bleeding events in patients with acute coronary syndromes. De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962 [TBL] [Abstract][Full Text] [Related]
26. Reducing the risk of emergency bypass surgery for failed percutaneous coronary interventions. Bittl JA J Am Coll Cardiol; 2005 Dec; 46(11):2010-2. PubMed ID: 16325033 [No Abstract] [Full Text] [Related]
27. Risks and benefits of antiplatelet therapy in uremic patients. Washam JB; Adams GL Adv Chronic Kidney Dis; 2008 Oct; 15(4):370-7. PubMed ID: 18805383 [TBL] [Abstract][Full Text] [Related]
28. Hazard--the anticoagulation bridge or just go transradial. Gilchrist IC Catheter Cardiovasc Interv; 2009 Jan; 73(1):48-9. PubMed ID: 19089937 [No Abstract] [Full Text] [Related]
29. Black and blue all over: a nice intervention or was it? Butman S Catheter Cardiovasc Interv; 2009 Jul; 74(1):74-5. PubMed ID: 19530205 [No Abstract] [Full Text] [Related]
30. Emerging insights on antiplatelet therapy. Introduction. Angiolillo DJ Am J Cardiol; 2009 Feb; 103(3 Suppl):1A-3A. PubMed ID: 19166706 [No Abstract] [Full Text] [Related]
31. [Postoperative complications during percutaneous coronary interventions- one more risk factor?]. Peruga JZ Kardiol Pol; 2009 Jul; 67(7):760-1. PubMed ID: 19750609 [No Abstract] [Full Text] [Related]
32. Coronary perforations: old screenplay, new actors! Colombo A; Stankovic G J Invasive Cardiol; 2004 Jun; 16(6):302-3. PubMed ID: 15155998 [No Abstract] [Full Text] [Related]
33. [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. Bassand JP; Hamm CW; Ardissino D; Boersma E; Budaj A; Fernandez-Aviles F; Fox KA; Hasdai D; Ohman EM; Wallentin L; Wijns W; Rev Port Cardiol; 2008 Sep; 27(9):1063-143. PubMed ID: 19044176 [No Abstract] [Full Text] [Related]
34. Options and outcomes with different antiplatelet strategies during primary percutaneous coronary intervention. Rajan L; Moliterno DJ Eur Heart J; 2009 Jul; 30(14):1687-9. PubMed ID: 19429914 [No Abstract] [Full Text] [Related]
35. Bleeding and transfusion in acute coronary syndromes: a shift in the paradigm. Bassand JP Heart; 2008 May; 94(5):661-6. PubMed ID: 18411361 [No Abstract] [Full Text] [Related]
36. Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Willis P; Voeltz MD Am J Cardiol; 2009 Sep; 104(5 Suppl):34C-8C. PubMed ID: 19695359 [TBL] [Abstract][Full Text] [Related]
37. New technique for quick and safe femoral artery access. Ghahramani AR Catheter Cardiovasc Interv; 2005 Feb; 64(2):256. PubMed ID: 15678466 [No Abstract] [Full Text] [Related]
38. High-dose, bolus-only, glycoprotein IIb/IIIa inhibitors for elective coronary intervention: logical, safe, cost-effective, and it works! Fischell TA J Invasive Cardiol; 2008 Feb; 20(2):59-60. PubMed ID: 18252968 [No Abstract] [Full Text] [Related]